Larry Dobrow is the Editor In Chief at Campaign US. He covers critical topics such as Google, security, security breaches, and AI, focusing on the intersection of technology and its implications for the industry. Larry's insights and expertise have been featured in Campaign US, PRWeek, and MM+M.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Larry Dobrow's articles primarily focus on the healthcare and pharmaceutical industry, with a significant emphasis on press releases and private sector announcements. His coverage also includes themes related to sales & marketing.
When reaching out to Larry, consider providing newsworthy press releases or exclusive data that can contribute to discussions around the latest developments in the healthcare and pharmaceutical sectors. Additionally, if you have insights into trends or innovations within sales & marketing strategies specific to these industries, it could capture his interest.
Since there is no specified geographic focus for Larry Dobrow's coverage, pitches should be relevant at an international level within the healthcare and pharmaceutical industry.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Revenue jumped 35% to $15 million.
Revenue grew 3% to $19.6 million.
2023 performance: $9.3 million.
2023 performance: $9.9 million.
61,114 words. 334 images. 23 new arrivals to the Top 100. MM+M's 2024 Agency 100 is all about the numbers.
2023 performance: $11 million (MM+M estimate).
2023 performance: $4.5 million.
Carter spent more than 35 years at AbelsonTaylor before a short stint at Juice Pharma Worldwide.
The media shop launches with 20 full-timers and VP, media strategy Christie Volke at the helm.
All media is, to some extent, health media — and every story MM+M writes, podcast it records or event it stages has a media component. It's not just a topic we survey once a year in between deconstructions of the patient journey.
(833) 317-6278 
